Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SLS
SLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SLS News
SLS and ATNM Present Key Data Catalysts Ahead of AACR Summit
23h ago
stocktwits
Sellas Life Sciences Advances SLS009 Therapy for AML
3d ago
stocktwits
Copper Supply Shortage Intensifies, Salazar Resources Poised for Growth
4d ago
Globenewswire
AMEX SUSPENDS NEWS PENDING LST 9.270000
Apr 09 2026
moomoo
Sellas to Present New SLS009 Data at AACR Meeting
Apr 09 2026
stocktwits
Investors Focus on Middle East Developments and Job Data
Mar 26 2026
stocktwits
Merck's Acquisition Sparks Interest in Blood Cancer Drug Market
Mar 26 2026
stocktwits
SLS Shares Surge Following Merck's Tern Acquisition, Fueling Buyout Speculation in Blood Cancer Sector: Retail Investors Eye Major Pharma Contender
Mar 26 2026
stocktwits
SLS vs. TERN: Which Pharmaceutical Stock Offers Greater Potential as Merck Plans $6B Investment in Cancer Ahead of Keytruda Patent Expiration?
Mar 25 2026
stocktwits
Sellas Life Sciences Shows Significant Clinical Progress
Mar 20 2026
stocktwits
SELLAS Life Sciences Reports 2025 Financials and Clinical Updates
Mar 20 2026
NASDAQ.COM
Sellas Life Sciences Narrows FY25 Net Loss Amid Promising Trials
Mar 20 2026
stocktwits
SELLAS Life Sciences FY 2025 Earnings Beat Expectations
Mar 19 2026
seekingalpha
Sellas Life Sciences Highlights Promising Data for AML Drug SLS009 Ahead of AACR 2026
Mar 18 2026
stocktwits
SELLAS Initiates Phase 2 Trial for SLS009 in AML
Mar 12 2026
stocktwits
Sellas' Immunotherapy Trial Approaches Key Milestone
Mar 10 2026
stocktwits
Show More News
